Ozempic Could Be Lifesaving for Thousands of Americans a Year, Study Finds
New research estimates that expanded access to Ozempic and similar drugs could lead to 42,000 deaths prevented annually.
ENDPOINTS NEWS5h
FDA won't take ac­tion against GLP-1 com­pounders as it re­thinks tirzepatide short­age
The FDA clarified Thursday that it won't take action against GLP-1 compounders for certain violations while it reevaluates ...
Managed Healthcare Executive6h
In the Real World, People Do Not Stick With GLP-1s for Weight Loss | AMCP Nexus 2024
Only 15% of those who start a glucagon-like peptide 1 (GLP-1) for weight loss are still taking it two years according to ...
Endocrinology Advisor12h
FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now
Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the FDA revisits its decision to remove it.
ENDPOINTS NEWS2d
Com­pound­ing as­so­ci­a­tion to ask for clar­i­ty around tirzepatide's short­age sta­tus
The Alliance for Pharmacy Compounding (APC) wants clarity around the FDA’s decision to reconsider tirzepatide’s removal from ...
Health.com2d
What the End of a Tirzepatide Shortage Would Mean for Access to Compounded Weight Loss Drugs
In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...
Mounjaro is more effective for weight loss than Ozempic—how does it work? And why does it cost so much?
,A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia. The drug, tirzepatide, is ...
Eli Lilly's tirzepatide is off the FDA's shortage list: What it means for patients
Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies ...
Should Eli Lilly Investors Worry About This Unexpected FDA Move?
Eli Lilly (NYSE: LLY) sells treatments for a wide variety of therapeutic areas, but one portfolio in particular has driven ...
Compounding pharmacies can make tirzepatide again
Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Compounding pharmacies can make tirzepatide againIn a reversal, the Food and Drug Administration ...
National Health Executive14d
Mounjaro: NICE consults on NHSE proposals for ’unprecedented’ obesity drug roll-out
The National Institute for Health and Care Excellence is consulting on a phased roll-out of Eli Lilly’s weight loss drug tirzepatide – more commonly known as Mounjaro – as NHS England looks to combat ...
Benzinga.com14d
England's NHS Proposes Phased Rollout of Eli Lilly's Mounjaro, Considers Digital Services to Boost Access
NHS England has proposed a phased rollout of tirzepatide, a promising weight-loss drug, to benefit patients most likely to achieve significant clinical outcomes. In the SURMOUNT-4 trial ...